- N,α-DEPEA
- N,α-Diethylphenylethylamine
- N-Ethyl-PBA
King, LA. New phenethylamines in Europe. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570
EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Pawar, RS; Grundel, E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test. Anal., 1 Mar 2017, 9 (3), 500-517. 601 kB. https://doi.org/10.1002/dta.1980
Jr, FTN; Clark, CR; Pitts-monk, P; De Ruiter, J. Liquid chromatographic and mass spectral analysis of 1-phenyl-2-butanamines: Homologues of the amphetamines. J. Liq. Chromatogr., 1 Apr 1991, 14 (7), 1393-1408. 450 kB. https://doi.org/10.1080/01483919108049327 LC,MS,UV
Kolaczynska, KE; Ducret, P; Trachsel, D; Hoener, MC; Liechti, ME; Luethi, D. Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA. Eur. Neuropsychopharmacol., 1 Jun 2022, 59, 9–22. 1.5 MB. https://doi.org/10.1016/j.euroneuro.2022.03.006 #N,α-DEPEA